Volume 55, Issue 6, Pages (June 2009)

Slides:



Advertisements
Similar presentations
Volume 60, Issue 5, Pages (November 2011)
Advertisements

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Volume 58, Issue 2, Pages (August 2010)
Maurizio Brausi, Federica Rizzi, Saverio Bettuzzi  European Urology 
Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes  Meng S. Shao, MD, Andrew T. Wong, MD,
Volume 60, Issue 2, Pages (August 2011)
Volume 64, Issue 6, Pages (December 2013)
Volume 61, Issue 5, Pages (May 2012)
Volume 53, Issue 5, Pages (May 2008)
Volume 69, Issue 1, Pages 4-6 (January 2016)
Volume 71, Issue 6, Pages e171-e172 (June 2017)
Let the Games Begin (with EAU Approval)
Volume 72, Issue 5, Pages (November 2017)
Volume 51, Issue 5, Pages (May 2007)
Prostate Cancer Epidemic in Sight?
Volume 52, Issue 4, Pages (October 2007)
Volume 61, Issue 4, Pages (April 2012)
Volume 71, Issue 2, Pages (February 2017)
Volume 50, Issue 5, Pages (November 2006)
Volume 59, Issue 2, Pages (February 2011)
Volume 63, Issue 1, Pages (January 2013)
Treatment of Advanced and Metastatic Renal Cancer: A Revolution?
Volume 66, Issue 2, Pages (August 2014)
The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.
The Role of Surgery in Metastatic Bladder Cancer: A Systematic Review
Volume 61, Issue 5, Pages (May 2012)
Ute Ganswindt, Arnulf Stenzl, Michael Bamberg, Claus Belka 
Volume 70, Issue 3, Pages (September 2016)
Volume 67, Issue 3, Pages (March 2015)
Volume 64, Issue 5, Pages (November 2013)
Low-risk Prostate Cancer: Identification, Management, and Outcomes
Volume 63, Issue 5, Pages (May 2013)
Contemporary Management of Postchemotherapy Testis Cancer
Volume 64, Issue 3, Pages (September 2013)
Hepatic resection of non-colorectal and non-neuroendocrine liver metastases – Survival benefit for patients with non-gastrointestinal primary cancers.
Surgery in Metastatic Testicular Cancer
Prostate Cancer Epidemic in Sight?
Volume 53, Issue 2, Pages (February 2008)
Volume 71, Issue 6, Pages (June 2017)
Volume 64, Issue 4, Pages (October 2013)
Volume 74, Issue 3, Pages (September 2018)
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Volume 53, Issue 6, Pages (June 2008)
Volume 63, Issue 3, Pages (March 2013)
Long-term Cancer-specific Survival in Patients with High-risk, Non–muscle-invasive Bladder Cancer and Tumour Progression: A Systematic Review  Sven van.
Shifting Paradigms for High-grade Prostatic Intraepithelial Neoplasia
Volume 71, Issue 1, Pages (January 2017)
Might Men Diagnosed with Metastatic Prostate Cancer Benefit from Definitive Treatment of the Primary Tumor? A SEER-Based Study  Stephen H. Culp, Paul.
The Economic Costs of Overactive Bladder in Germany
Volume 53, Issue 1, Pages (January 2008)
Volume 62, Issue 6, Pages (December 2012)
Volume 50, Issue 5, Pages (November 2006)
Volume 52, Issue 6, Pages (December 2007)
Volume 55, Issue 6, Pages (June 2009)
Volume 71, Issue 5, Pages (May 2017)
Testicular Cancer Variations in Time and Space in Europe
Maurizio Brausi, Federica Rizzi, Saverio Bettuzzi  European Urology 
The 20-Yr Outcome in Patients with Well- or Moderately Differentiated Clinically Localized Prostate Cancer Diagnosed in the Pre-PSA Era: The Prognostic.
Volume 75, Issue 4, Pages (April 2019)
European Urology is “Your” Journal
Volume 74, Issue 6, Pages (December 2018)
Volume 55, Issue 6, Pages (June 2009)
Axel Heidenreich  European Urology Supplements 
Volume 52, Issue 4, Pages (October 2007)
European Association of Urology Guidelines for Systemic Therapy in Metastatic Renal Cell Carcinoma: What is Recommended and Why?  Jean-Jacques Patard 
Volume 53, Issue 6, Pages (June 2008)
Volume 52, Issue 1, Pages (July 2007)
James D Luketich, Michael E Burt  The Annals of Thoracic Surgery 
Axel Heidenreich  European Urology Supplements 
Volume 54, Issue 1, Pages (July 2008)
Presentation transcript:

Volume 55, Issue 6, Pages 1293-1299 (June 2009) Surgery for Metastatic Urothelial Carcinoma with Curative Intent: The German Experience (AUO AB 30/05)  Jan Lehmann, Henrik Suttmann, Peter Albers, Björn Volkmer, Jürgen E. Gschwend, Guido Fechner, Martin Spahn, Axel Heidenreich, Axel Odenthal, Christoph Seif, Nils Nürnberg, Christian Wülfing, Christoph Greb, Tilmann Kälble, Marc-Oliver Grimm, Claus Friedrich Fieseler, Susanne Krege, Margitta Retz, Heiner Schulte-Baukloh, Martin Gerber, Markus Hack, Jörn Kamradt, Michael Stöckle  European Urology  Volume 55, Issue 6, Pages 1293-1299 (June 2009) DOI: 10.1016/j.eururo.2008.11.039 Copyright © 2008 European Association of Urology Terms and Conditions

Fig. 1 Kaplan-Meier analyses of overall (panels A and B), cancer-specific (panels C and D) and progression-free (panels E and F) survival from first diagnosis and subsequent resection of urothelial carcinoma metastases (UCM). European Urology 2009 55, 1293-1299DOI: (10.1016/j.eururo.2008.11.039) Copyright © 2008 European Association of Urology Terms and Conditions